{"id":"https://openalex.org/W7014672104","doi":null,"title":"A randomized controlled trial of ranibizumab with and without indomethacin eyedrops for exudative age-related macular degeneration","display_name":"A randomized controlled trial of ranibizumab with and without indomethacin eyedrops for exudative age-related macular degeneration","alternate_titles":[],"publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W7014672104"},"language":"en","primary_location":{"id":"pmh:oai:iris.unibs.it:11379/484420","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11379/484420","pdf_url":null,"source":{"id":"https://openalex.org/S4306400804","display_name":"Institutional Research Information System (Universit\u00e0 degli Studi di Brescia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/conferenceObject"},"parent_works":[],"lineage":["https://openalex.org/W7014672104"],"child_works_count":0,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"RUSSO, Andrea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RUSSO, Andrea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"SEMERARO, Francesco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SEMERARO, Francesco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045153247","display_name":"Francesco Morescalchi","orcid":"https://orcid.org/0000-0002-3553-0736","observed_orcids":["https://orcid.org/0000-0002-3553-0736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morescalchi, Francesco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Costagliola, Ciro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Costagliola, Ciro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Ferrante, Gloria","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ferrante, Gloria","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9279999732971191},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.9990000128746033},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.8299999833106995},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7829999923706055},{"id":"https://openalex.org/keywords/central-macular-thickness","display_name":"central macular thickness","score":0.8899999856948853},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.8080000281333923},{"id":"https://openalex.org/keywords/topical-anti-inflammatory-therapy","display_name":"topical anti-inflammatory therapy","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C144251240","wikidata":"https://www.wikidata.org/wiki/Q7068229","display_name":"Nucleofection","level":4,"score":0.4449999928474426},{"id":"https://openalex.org/C2992336715","wikidata":"https://www.wikidata.org/wiki/Q63431143","display_name":"Gestational period","level":4,"score":0.34380000829696655},{"id":"https://openalex.org/C133074676","wikidata":"https://www.wikidata.org/wiki/Q428729","display_name":"Fusible alloy","level":2,"score":0.34220001101493835},{"id":"https://openalex.org/C2778283623","wikidata":"https://www.wikidata.org/wiki/Q18032200","display_name":"TSG101","level":5,"score":0.31690001487731934},{"id":"https://openalex.org/C2777054765","wikidata":"https://www.wikidata.org/wiki/Q6402731","display_name":"Dysgeusia","level":3,"score":0.31470000743865967},{"id":"https://openalex.org/C18743360","wikidata":"https://www.wikidata.org/wiki/Q1208096","display_name":"Diafiltration","level":4,"score":0.3019999861717224},{"id":"https://openalex.org/C145741570","wikidata":"https://www.wikidata.org/wiki/Q7251534","display_name":"Proteogenomics","level":5,"score":0.3003999888896942},{"id":"https://openalex.org/C2777158700","wikidata":"https://www.wikidata.org/wiki/Q1419356","display_name":"Hyporeflexia","level":3,"score":0.28999999165534973},{"id":"https://openalex.org/C2781032047","wikidata":"https://www.wikidata.org/wiki/Q938793","display_name":"Articular cartilage damage","level":5,"score":0.2897999882698059},{"id":"https://openalex.org/C180938184","wikidata":"https://www.wikidata.org/wiki/Q2142270","display_name":"Liquation","level":3,"score":0.2874999940395355},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.2867000102996826},{"id":"https://openalex.org/C2779627259","wikidata":"https://www.wikidata.org/wiki/Q779763","display_name":"Pretext","level":3,"score":0.2815000116825104},{"id":"https://openalex.org/C2776781215","wikidata":"https://www.wikidata.org/wiki/Q83253","display_name":"Triacetin","level":2,"score":0.2791999876499176},{"id":"https://openalex.org/C2779640190","wikidata":"https://www.wikidata.org/wiki/Q1956682","display_name":"Myoglobinuria","level":3,"score":0.2667999863624573},{"id":"https://openalex.org/C2777935831","wikidata":"https://www.wikidata.org/wiki/Q3144949","display_name":"Hemopericardium","level":3,"score":0.26260000467300415},{"id":"https://openalex.org/C135979968","wikidata":"https://www.wikidata.org/wiki/Q609809","display_name":"Protein isoform","level":5,"score":0.2581999897956848},{"id":"https://openalex.org/C2780904289","wikidata":"https://www.wikidata.org/wiki/Q426498","display_name":"Tantalum carbide","level":3,"score":0.25540000200271606},{"id":"https://openalex.org/C2778902089","wikidata":"https://www.wikidata.org/wiki/Q5608642","display_name":"Subpoena","level":2,"score":0.2547999918460846},{"id":"https://openalex.org/C2777738910","wikidata":"https://www.wikidata.org/wiki/Q3790542","display_name":"Sulfinpyrazone","level":3,"score":0.25189998745918274},{"id":"https://openalex.org/C168481208","wikidata":"https://www.wikidata.org/wiki/Q2464757","display_name":"Tachyphylaxis","level":2,"score":0.2515999972820282}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:iris.unibs.it:11379/484420","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11379/484420","pdf_url":null,"source":{"id":"https://openalex.org/S4306400804","display_name":"Institutional Research Information System (Universit\u00e0 degli Studi di Brescia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2794825006","https://openalex.org/W2992038896","https://openalex.org/W2143081671","https://openalex.org/W2992652733","https://openalex.org/W2092174330","https://openalex.org/W2314031220","https://openalex.org/W2076285410","https://openalex.org/W2742101666","https://openalex.org/W2170468054","https://openalex.org/W2745726850"],"abstract_inverted_index":{"Purpose":[0],"To":[1],"assess":[2],"whether":[3],"indomethacin":[4,50,130,143],"eye":[5,131],"drops":[6,132],"and":[7,35,48,123,133],"intravitreal":[8],"ranibizumab":[9],"(IVR)":[10],"would":[11],"provide":[12],"additional":[13],"\\nbenefit":[14],"over":[15],"IVR":[16,53,134,148],"alone":[17],"in":[18,37,65,70,75,87,105,136,149,152],"the":[19,76,88,91,101,116,121,145],"treatment":[20,44,103],"of":[21,29,125,128,147],"nai\u0308ve":[22],"choroidal":[23],"neovascularization":[24],"(CNV).":[25],"Methods":[26],"A":[27],"total":[28],"22":[30],"\\npatients":[31],"were":[32],"enrolled":[33],"consecutively":[34],"randomized":[36],"a":[38,62,106,126],"1:1":[39],"ratio":[40],"to":[41,118],"receive":[42],"combination":[43,77,102,127],"with":[45,138],"monthly":[46,52],"\\nIVR":[47],"topical":[49,142],"or":[51],"alone.":[54],"Results":[55],"At":[56],"6":[57],"months,":[58],"both":[59],"groups":[60],"showed":[61],"significant":[63],"\\nimprovement":[64],"BCVA.":[66],"The":[67],"mean":[68],"change":[69,92],"central":[71],"macular":[72],"thickness":[73],"(CMT)":[74],"group":[78],"was":[79,93],"\\n\u2212129.2":[80],"\u03bcm":[81],"(\u221230.1%;":[82],"P":[83,97],"<":[84,98],".01),":[85],"while":[86],"ranibizumab-only":[89],"group,":[90],"\u221286.9":[94],"mm":[95],"(\u221221.1%;":[96],".01);":[99],"\\nthus,":[100],"resulted":[104],"greater":[107],"reduction":[108],"(P":[109],"=":[110],".004).":[111],"Conclusion":[112],"This":[113],"pilot":[114],"study,":[115],"first":[117],"\\nprospectively":[119],"investigate":[120],"efficacy":[122],"safety":[124],"0.5%":[129],"\\ninjections":[135],"patients":[137],"CNV,":[139],"suggests":[140],"that":[141],"supplements":[144],"activity":[146],"reducing":[150],"\\nCMT":[151],"CNV":[153]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7014672104","counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}
